Melanoma Research Institute of Excellence

For more than 20 years, melanoma researchers at the Sidney Kimmel Comprehensive Cancer Center (SKCCC) have been at the forefront of groundbreaking discoveries, pioneering treatments, and advances in patient care. Building on this legacy of innovation, the Melanoma Research Institute of Excellence (MRIE) brings together leading experts to accelerate research, advance promising new therapies, and improve outcomes for patients facing these complex cancers.

The MRIE unites expertise in both uveal (eye) and cutaneous (skin) melanoma, fostering collaboration across laboratory, clinical, genetic, and population-based research. With a proven track record of translating scientific discoveries into first-in-field therapies and innovative treatment approaches, our researchers are working to uncover new insights, overcome longstanding challenges, and expand treatment options for patients. This multidisciplinary approach strengthens the connection between scientific discovery and clinical care, helping bring the next generation of melanoma therapies from the laboratory to the patients who need them.

Our mission is clear: to advance the prevention, early detection, and treatment of melanoma while working toward a future free from these devastating cancers. Every discovery brings us closer to more effective therapies, better outcomes, and ultimately, cures. Through the MRIE, we are transforming the promise of research into meaningful progress for patients at Jefferson and around the world.